NDC 17856-0060-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0060
- Requested NDC
- 17856-0060-01
- Package NDCs from labels
- 17856-0060-1, 17856-0060-3, 17856-0060-2, 17856-0060-4, 17856-0060-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MEGESTROL ACETATE ORAL SUSPENSION, USP | ATLANTIC BIOLOGICALS CORP. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0060-1 | Megestrol Acetate | 10 mL in 1 CUP | SUSPENSION | 10 | 3 | |
| 17856-0060-2 | Megestrol Acetate | 20 mL in 1 CUP | SUSPENSION | 20 | 3 | |
| 17856-0060-3 | Megestrol Acetate | 72 in 1 BOX | SUSPENSION | 72 | 3 | |
| 17856-0060-4 | Megestrol Acetate | 50 in 1 BOX | SUSPENSION | 50 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0060 | MEGESTROL ACETATE SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, Legacy NDC, 4 package rows | 20250524_01119031-9943-4afb-8b45-cb71682f0482.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Laxative | DOCUSATE SODIUM | Major Pharmaceuticals | 97561cd4-63d9-44c2-a3a3-ec668a09a4ed | 2025-10-31 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM, SENNOSIDES | Family Dollar (FAMILY WELLNESS) | 1eee3ed5-09f7-44a9-abc5-98336e493fe8 | 2025-10-30 | Warnings | F05Q2T2JA0 |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Publix Super Markets Inc | 354a640c-bc7e-45c8-9df0-8b5b01767f5c | 2025-10-29 | Warnings | PDC6A3C0OX |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | PDC6A3C0OX |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | 90a4d385-d548-420b-91d2-54d5e819fcce | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 3a59c4a9-5f86-406a-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Cardinal Health | 7e7e9366-af1e-e0ff-e053-2a91aa0a9487 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Cardinal Health | c2b02afc-5a8a-2a25-e053-2a95a90ae45c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Signature Care Hemorrhoidal Cream (with applicator) | PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, GLYCERIN, PETROLATUM | BETTER LIVING BRANDS, LLC | b026a386-5e38-52ed-e053-2a95a90a6b0e | 2025-10-24 | Warnings | PDC6A3C0OX |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.